Joss RA - Search Results

1

Early versus late alternating chemotherapy in small-cell lung cancer. Swiss Group for Clinical Cancer Research (SAKK).

Joss RA, Bacchi M, Hürny C, Bernhard J, Cerny T, Martinelli G, Leyvraz S, Senn HJ, Stahel R, Siegenthaler P, et al. Joss RA, et al. Ann Oncol. 1995 Feb;6(2):157-66. doi: 10.1093/oxfordjournals.annonc.a059111. Ann Oncol. 1995. PMID: 7786823 Free article. Clinical Trial.

2

Feasibility of quality of life assessment in a randomized phase III trial of small cell lung cancer--a lesson from the real world--the Swiss Group for Clinical Cancer Research SAKK.

Hürny C, Bernhard J, Joss R, Willems Y, Cavalli F, Kiser J, Brunner K, Favre S, Alberto P, Glaus A, et al. Hürny C, et al. Ann Oncol. 1992 Dec;3(10):825-31. doi: 10.1093/oxfordjournals.annonc.a058104. Ann Oncol. 1992. PMID: 1337466 Free article. Clinical Trial.

3

Chemotherapy with MACOP-B and VACOP-B for intermediate- and high-grade non-Hodgkin's lymphoma: clinical results and analysis of prognostic factors.

Pichert G, Peters J, Stahel RA, Dommann C, Joss R, Gebbers JO, Kroner T, Sulser H, Honegger HP, Maurer R, et al. Pichert G, et al. Among authors: joss r. Ann Oncol. 1992 Sep;3(8):645-9. doi: 10.1093/oxfordjournals.annonc.a058295. Ann Oncol. 1992. PMID: 1280460 Free article.

4

Quality versus quantity of life in the treatment of patients with advanced small-cell lung cancer? A randomized phase III comparison of weekly carboplatin and teniposide versus cisplatin, adriamycin, etoposide alternating with cyclophosphamide, methotrexate, vincristine and lomustine. Swiss Group for Clinical Cancer Research (SAKK).

Joss RA, Alberto P, Hürny C, Bacchi M, Leyvraz S, Thürlimann B, Cerny T, Martinelli G, Stahel R, Ludwig C. Joss RA, et al. Ann Oncol. 1995 Jan;6(1):41-8. doi: 10.1093/oxfordjournals.annonc.a059039. Ann Oncol. 1995. PMID: 7536028 Free article. Clinical Trial.

5

Combined-modality treatment of small-cell lung cancer: randomized comparison of three induction chemotherapies followed by maintenance chemotherapy with or without radiotherapy to the chest. Swiss Group for Clinical Cancer Research (SAKK).

Joss RA, Alberto P, Bleher EA, Ludwig C, Siegenthaler P, Martinelli G, Sauter C, Schatzmann E, Senn HJ. Joss RA, et al. Ann Oncol. 1994 Dec;5(10):921-8. doi: 10.1093/oxfordjournals.annonc.a058731. Ann Oncol. 1994. PMID: 7696164 Free article. Clinical Trial.

6

Ondansetron plus dexamethasone is superior to ondansetron alone in the prevention of emesis in chemotherapy-naive and previously treated patients. Swiss Group for Clinical Cancer Research (SAKK).

Joss RA, Bacchi M, Buser K, Kirchner V, Neuenschwander H, Orth B, Aapro MS, Thürlimann B. Joss RA, et al. Ann Oncol. 1994 Mar;5(3):253-8. doi: 10.1093/oxfordjournals.annonc.a058803. Ann Oncol. 1994. PMID: 8186174 Free article. Clinical Trial.

7

Initial prognostic factors in small-cell lung cancer patients predicting quality of life during chemotherapy. Swiss Group for Clinical Cancer Research (SAKK).

Bernhard J, Hürny C, Bacchi M, Joss RA, Cavalli F, Senn HJ, Leyvraz S, Stahel R, Ludwig C, Alberto P. Bernhard J, et al. Among authors: joss ra. Br J Cancer. 1996 Nov;74(10):1660-7. doi: 10.1038/bjc.1996.606. Br J Cancer. 1996. PMID: 8932352 Free PMC article. Clinical Trial.

8

Continuous 5-day infusion of ifosfamide with mesna in inoperable pancreatic cancer patients: a phase II study.

Cerny T, Martinelli G, Goldhirsch A, Terrier F, Joss R, Fey MF, Brunner KW, Küpfer A. Cerny T, et al. J Cancer Res Clin Oncol. 1991;117 Suppl 4:S135-8. doi: 10.1007/BF01613218. J Cancer Res Clin Oncol. 1991. PMID: 1795002 Clinical Trial.

9

"Fatigue and malaise" as a quality-of-life indicator in small-cell lung cancer patients. The Swiss Group for Clinical Cancer Research (SAKK).

Hürny C, Bernhard J, Joss R, Schatzmann E, Cavalli F, Brunner K, Alberto P, Senn HJ, Metzger U. Hürny C, et al. Support Care Cancer. 1993 Nov;1(6):316-20. doi: 10.1007/BF00364969. Support Care Cancer. 1993. PMID: 8156249 Clinical Trial.

10

Combination chemotherapy with mitomycin, vindesine, and cisplatin for non-small cell lung cancer. Association of antitumor activity with initial tumor burden and treatment center.

Joss RA, Bürki K, Dalquen P, Schatzmann E, Leyvraz S, Cavalli F, Ludwig C, Siegenthaler P, Alberto P, Stahel R, et al. Joss RA, et al. Cancer. 1990 Jun 1;65(11):2426-34. doi: 10.1002/1097-0142(19900601)65:11<2426::aid-cncr2820651104>3.0.co;2-3. Cancer. 1990. PMID: 2159837 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

127 results

Search Page

Filters